Balance Sheets (USD $)	Mar. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 7,355	$ 7,261
Prepaid expense and other current assets	2,361	13,674
Total current assets	9,716	20,935
Patents, net	90,336	94,100
Total assets	100,052	115,035
Current liabilities:
Accounts payable and accrued expenses	337,326	360,353
Accrued interest - related parties	980,023	951,442
Accrued expenses – related party	78,360	78,360
Derivative liabilities		4,217
Notes payable – related parties	3,026,293	2,847,958
Total current liabilities	4,422,002	4,242,330
Total liabilities	4,422,002	4,242,330
Preferred stock, $0.01 par value: Authorized shares – 10,000,000 Issued and outstanding shares – 3,262 at March 31, 2013 and December 31, 2012	33	33
Common stock, $0.01par value: Authorized shares - 100,000,000 Issued and outstanding shares – 73,554,897 at March 31, 2013 and 73,554,897 at December 31, 2012	735,549	735,549
Additional paid-in capital	31,966,377	31,966,377
Accumulated deficit	(37,023,909)	(36,829,254)
Total stockholders' deficit	(4,321,950)	(4,127,295)
Total liabilities and stockholders’ deficit	$ 100,052	$ 115,035